or Try an Advanced Search...

    Technical Analysis for NBTX - Nanobiotix S.A.

    Grade Last Price % Change Price Change
    C 7.31 0.27% 0.02
    NBTX closed up 0.27 percent on Wednesday, May 15, 2024, on 7 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical NBTX trend table...
    Date Alert Name Type % Chg
    Doji - Bearish? Reversal 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Earnings Movers Other 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Crossed Above 200 DMA Bullish 0.27%
    Pocket Pivot Bullish Swing Setup 0.27%
    Older End-of-Day Signals for NBTX ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 13 hours ago
    Rose Above Previous Day's High about 15 hours ago
    Up 2% about 15 hours ago
    Up 1% about 15 hours ago
    Fell Below Upper Bollinger Band about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NBTX Chart by TradingView
    Basic chart:

    Profile

    Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges. Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy

    Is NBTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
    May 14 NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
    Apr 27 Nanobiotix S.A. (NBTX) Q4 2023 Earnings Call Transcript
    Apr 25 Nanobiotix reports FY results
    Apr 24 NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
    Apr 17 NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
    Apr 13 11 Best Nanotechnology Stocks To Invest In
    Apr 2 Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
    Mar 18 Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Mar 11 EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
    See more NBTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.0
    52 Week Low 4.55
    Average Volume 21,657
    200-Day Moving Average 7.07
    50-Day Moving Average 6.25
    20-Day Moving Average 6.20
    10-Day Moving Average 6.65
    Average True Range 0.35
    RSI (14) 69.70
    ADX 37.88
    +DI 40.04
    -DI 8.79
    Chandelier Exit (Long, 3 ATRs) 6.43
    Chandelier Exit (Short, 3 ATRs) 6.19
    Upper Bollinger Bands 7.31
    Lower Bollinger Band 5.10
    Percent B (%b) 1.0
    BandWidth 35.58
    MACD Line 0.26
    MACD Signal Line 0.11
    MACD Histogram 0.1579
    Fundamentals Value
    Market Cap 344.38 Million
    Num Shares 47.1 Million
    EPS -1.81
    Price-to-Earnings (P/E) Ratio -4.04
    Price-to-Sales 51.51
    Price-to-Book 65.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.76
    Resistance 3 (R3) 7.77 7.63 7.68
    Resistance 2 (R2) 7.63 7.52 7.62 7.66
    Resistance 1 (R1) 7.47 7.44 7.55 7.46 7.63
    Pivot Point 7.33 7.33 7.37 7.33 7.33
    Support 1 (S1) 7.17 7.22 7.25 7.16 6.99
    Support 2 (S2) 7.03 7.14 7.03 6.96
    Support 3 (S3) 6.87 7.03 6.94
    Support 4 (S4) 6.86